TrialJournal of the American Society of Nephrology : JASN2013
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
Neeraj Dhaun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it